Metabolic syndrome and chronic kidney disease in a Southern Chinese population

Nephrology

Volumn 19, Issue 6, 2014, Pages 325-331

  Li, Yongqiang ^a   Chen, Youming ^a   Liu, Xinyu ^a   Liang, Yan ^a   Shao, Xiaofei ^a   Zhang, Ying ^a   Wang, Honglei ^a   Wang, Xiaohong ^a   Li, Bin ^a   Deng, Kangping ^a   Liu, Qin ^a   Holthöfer, Harry ^b   Liu, Hongmei ^a   Zou, Hequn ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

chronic kidney disease; metabolic syndrome; Southern Chinese population

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; CENTRAL OBESITY; CHINESE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DATA ANALYSIS SOFTWARE; DIABETES MELLITUS; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; RISK; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84897856842     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12219     Document Type: Article

References (31)

1. Huang PL,. A comprehensive definition for metabolic syndrome. Dis. Model Mech. 2009; 2: 231-237.
2. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
3. Gu D, Reynolds K, Wu X, et al. InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
4. Laaksonen DE, Lakka HM, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 2002; 156: 1070-1077.
5. Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: A population-based study. Risk Factor and Life Expectancy Research Group. Am. J. Epidemiol. 1998; 148: 958-966.
6. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults 1999-2000. J. Am. Med. Assoc. 2002; 288: 1723-1727.
7. Wang H, Zhang L, Lv J,. Prevention of the progression of chronic kidney disease: practice in China. Kidney Int. Suppl. 2005; 94: S63-S67.
8. Dialysis and Transplantation Registration Group CSoNCMA. The report about the registration of dialysis and transplantation in China 1999. Chin. J. Nephrol. 2001; 17: 77-78.
9. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012; 379 (9818): 815-822.
10. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition examination Survey. JAMA 2002; 287: 356-359.
11. Kurella M, Lo JC, Chertow GM,. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J. Am. Soc. Nephrol. 2005; 16: 2134-2140.
12. Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin. Proc. 2007; 82: 822-827.
13. World Health Organization, Western Pacific Region, The International Association for the Study of Obesity and the International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Sydney, Australia: Health Communications Australia Pty Limited. 2000. [Cited 23 Aug 2006.] Available from URL: http://www.wpro.who.int/nutrition/documents/ Redefining-obesity/en/
14. Knapp ML, Hadid O,. Investigations into the negative interference by jaundiced plasma in kinetic Jaffe's methods for plasma creatinine estimation. Ann. Clin. Biochem. 1987; 24: 85-97.
15. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome part 1: worldwide definition for use in clinical practice. [Cited 11 May 2007.] Available from URL: www.idf.org/webdata/docs/IDF- metasyndrome-definition.pdf
16. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006; 17: 2937-2944.
17. Kurella M, Lo JC, Chertow GM,. Metabolic Syndrome and the risk for chronic kidney disease among nondiabetic adults. J. Am. Soc. Nephrol. 2005; 16: 2134-2140.
18. Palaniappan L, Carnethon M, Fortmann SP,. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am. J. Hypertens. 2003; 16 (11, pt 1): 952-958.
19. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann. Intern. Med. 2004; 140: 167-174.
20. Kitiyakara C, Yamwong S, Cheepudomwit S, et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int. 2007; 71: 693-700.
21. Chang IH, Han JH, Myung SC, et al. Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology 2009; 14: 321-326.
22. Li Y, Zhao D, Wang W, et al. A comparison of three diagnostic criterions for metabolic syndrome applied in a Chinese population aged 35-64 in 11 provinces. Zhonghua Liu Xing Bing Xue Za Zhi 2007; 28 (1): 83-87.
23. Fox CS, Larson MG, Leip EP, et al. Glycemic status and development of kidney disease: The Framingham Heart Study. Diabetes Care 2005; 28: 2436-2440.
24. Culleton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999; 56: 2214-2219.
25. Barri YM,. Hypertension and kidney disease: A deadly connection. Curr. Cardiol. Rep. 2006; 8: 411-417.
26. Oda E, Kawai R,. Low-density lipoprotein (LDL) cholesterol is cross-sectionally associated with preclinical chronic kidney disease (CKD) in Japanese men. Intern. Med. 2010; 49: 713-719.
27. Tozawa M, Iseki K, Iseki C, et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002; 62: 1743-1749.
28. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study. Kidney Int. 2000; 58: 293-301.
29. Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens. Res. 2007; 30: 937-943.
30. Jang SY, Kim IH, Ju EY, et al. Chronic kidney disease and metabolic syndrome in a general Korean population: The Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study. Journal of Public Health 2010; 32: 538-546.
31. Hall JE, Brands MW, Henegar JR,. Mechanisms of hypertension and kidney disease in obesity. Ann. N.Y. Acad. Sci. 1999; 892: 91-107.